J. Graham White

Q: What Schools Are Affiliated With J. Graham White

J. Graham White is affiliated with the following schools: University of Minnesota, Icahn School of Medicine at Mount Sinai

J. Graham White's AcademicInfluence.com Rankings

J. Graham White

Biology

#2422

World Rank

#3841

Historical Rank

Neuroscience

#208

World Rank

#220

Historical Rank

biology Degrees

Download Badge

Biology

Why Is J. Graham White Influential?

(Suggest an Edit or Addition)

(See a Problem?)

J. Graham White's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The structure of the nervous system of the nematode Caenorhabditis elegans. (1986) (5274)
The embryonic cell lineage of the nematode Caenorhabditis elegans. (1983) (3928)
The neural circuit for touch sensitivity in Caenorhabditis elegans (1985) (1021)
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. (1967) (918)
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. (1977) (645)
The structure of the ventral nerve cord of Caenorhabditis elegans. (1976) (644)
On the control of germ cell development in Caenorhabditis elegans. (1981) (599)
Regulation and cell autonomy during postembryonic development of Caenorhabditis elegans. (1980) (581)
Cortical flow in animal cells. (1988) (556)
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. (1980) (405)
Determination of cell division axes in the early embryogenesis of Caenorhabditis elegans (1987) (350)
Effect of cholesterol on production of thromboxane b2 by platelets in vitro. (1980) (337)
Fine structural alterations induced in platelets by adenosine diphosphate. (1968) (337)
Cortical and cytoplasmic flow polarity in early embryonic cells of Caenorhabditis elegans (1993) (306)
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. (2001) (298)
Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. (1999) (285)
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. (1980) (277)
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. (1979) (270)
Interaction of membrane systems in blood platelets. (1972) (263)
On the mechanisms of cytokinesis in animal cells. (1983) (247)
An ultrastructural basis for the shape changes induced in platelets by chilling. (1967) (239)
The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. (1974) (220)
Cell fusions in the developing epithelial of C. elegans. (1994) (198)
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. (1980) (192)
Replication occurs at discrete foci spaced throughout nuclei replicating in vitro. (1989) (190)
Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. (1970) (186)
Mitogenic properties of a calcium ionophore, A23187. (1974) (181)
Polyploid tissues in the nematode Caenorhabditis elegans. (1985) (179)
Ultrastructure of clots during isometric contraction (1982) (177)
Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. (1985) (176)
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. (1974) (173)
Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. (1979) (168)
Formation of the vulva in Caenorhabditis elegans: a paradigm for organogenesis. (1999) (166)
Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. (1971) (165)
The spd-2 gene is required for polarization of the anteroposterior axis and formation of the sperm asters in the Caenorhabditis elegans zygote. (2000) (161)
Proteomic analysis of platelet alpha-granules using mass spectrometry. (2007) (150)
Morphogenesis of the C. elegans hermaphrodite uterus. (1996) (146)
The Chediak-Higashi syndrome: a possible lysosomal disease. (1966) (141)
The Hermansky-Pudlak syndrome. (1997) (136)
Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. (1988) (135)
The C. elegans septin genes, unc-59 and unc-61, are required for normal postembryonic cytokineses and morphogenesis but have no essential function in embryogenesis. (2000) (135)
Localization of platelet prostaglandin production in the platelet dense tubular system. (1976) (134)
Plasminogen interacts with human platelets through two distinct mechanisms. (1986) (132)
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. (1970) (129)
A genetic screen for temperature-sensitive cell-division mutants of Caenorhabditis elegans. (1998) (127)
Mutations in the Caenorhabditis elegans unc–4 gene alter the synaptic input to ventral cord motor neurons (1992) (126)
The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles. (1969) (122)
Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. (1974) (118)
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. (1968) (114)
The fate of the open canalicular system in surface and suspension-activated platelets. (1989) (113)
The platelet open canalicular system: a final common pathway. (1991) (107)
The surface-connected canalicular system of blood platelets--a fenestrated membrane system. (1980) (107)
Platelet interaction with bacteria. II. Fate of the bacteria. (1971) (107)
Ultrastructural features of abnormal blood platelets. A review. (1976) (106)
Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate. (1974) (106)
Studies of platelets in a variant of the Hermansky-Pudlak syndrome. (1971) (105)
The Caenorhabditis elegans lin-12 gene mediates induction of ventral uterine specialization by the anchor cell. (1995) (104)
Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. (1991) (103)
Ultrastructural studies of the gray platelet syndrome. (1979) (100)
Cyclic AMP and platelet prostaglandin synthesis. (1977) (96)
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. (1998) (94)
Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. (1992) (93)
Influence of epinephrine on the aggregation response of aspirin-treated platelets. (1980) (93)
Effects of ethylenediamine tetracetic acid (EDTA) on platelet structure. (2009) (91)
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. (2001) (90)
Ibuprofen Protects Platelet Cyclooxygenase from Irreversible Inhibition by Aspirin (1983) (89)
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. (1974) (89)
Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease. Evidence for the role of lipid peroxidation. (1983) (88)
Platelet interaction with bacteria. IV. Stimulation of the release reaction. (1975) (86)
The Chediak-Higashi syndrome: formation of giant melanosomes and the basis of hypopigmentation. (1967) (83)
Cell cycling and DNA replication in a mutant blocked in cell division in the nematode Caenorhabditis elegans. (1978) (83)
A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. (1995) (83)
Fibrinogen is the receptor for the endogenous lectin of human platelets (1981) (83)
Uptake of Calcium by Platelet Relaxing Factor (1969) (83)
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. (1983) (81)
Arachidonate-induced platelet aggregation in the dog. (1979) (81)
Effects of an ionophore, A23187, on the surface morphology of normal erythrocytes. (1974) (79)
Use of the electron microscope for diagnosis of platelet disorders. (1998) (78)
Further studies of the secretory pathway in thrombin-stimulated human platelets. (1987) (77)
Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis. (1979) (76)
Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts. (1967) (76)
Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. (1991) (76)
Factors that determine connectivity in the nervous system of Caenorhabditis elegans. (1983) (74)
Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. (1967) (74)
Organization of the actin cytoskeleton of resting and activated platelets in suspension. (1986) (72)
Ophthalmologic, biochemical, platelet, and ultrastructural defects in the various types of oculocutaneous albinism. (1973) (72)
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. (1986) (71)
Paris‐Trousseau syndrome platelets in a child with Jacobsen's syndrome (2001) (71)
Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion. (1993) (71)
The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension. (1989) (70)
Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study. (1989) (70)
Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. (1968) (70)
High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s). (1986) (69)
Heterogeneous abnormalities of platelet dense granule ultrastructure in 20 patients with congenital storage pool deficiency (1993) (68)
Uptake of latex particles by blood platelets: phagocytosis or sequestration? (1972) (68)
The fine structure of sickled hemoglobin in situ. (1968) (65)
Current concepts of platelet structure. (1979) (64)
An improved method for the extraction of endogenous platelet serotonin. (1976) (63)
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. (1974) (63)
Autosomal recessive oculocutaneous albinism in man. Evidence for genetic heterogeneity. (1970) (63)
The secretory pathway of bovine platelets. (1987) (62)
Epinephrine potentiation of arachidonate‐induced aggregation of cyclooxygenase‐deficient platelets (1981) (61)
Erythrocyte Pathology and Mechanisms of Heinz Body-mediated Hemolysis in Cats (1990) (61)
Hypopigmentation in the Prader-Willi syndrome. (1987) (61)
The Chédiak-Higashi syndrome; the nature of the giant neutrophil granules and their interactions with cytoplasm and foreign particulates. I. Progressive enlargement of the massive inclusions in mature neutrophils. II. Manifestations of cytoplasmic injury and sequestration. III. Interactions between (1980) (60)
Platelet Storage Pool Deficiency and Prostaglandin Synthesis in Chronic Granulocytic Leukaemia (1978) (60)
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. (1985) (60)
Clinical and cellular characterisation of Hermansky–Pudlak syndrome type 6 (2009) (60)
Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B. (1978) (60)
Recycling of platelet phosphorylation and cytoskeletal assembly (1984) (59)
Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. (1997) (59)
The dense bodies of human platelets. Origin of serotonin storage particles from platelet granules. (1968) (59)
Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. (1994) (59)
Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. (1987) (58)
The transfer of thorium particles from plasma to platelets and platelet granules. (1968) (58)
Membrane abnormalities of irreversibly sickled cells. (1979) (58)
Decreased survival in vivo of diamide-incubated dog erythrocytes. A model of oxidant-induced hemolysis. (1980) (57)
Influence of a microtubule stabilizing agent on platelet structural physiology. (1983) (57)
THE PLATELET-FIBRIN RELATIONSHIP IN HUMAN BLOOD CLOTS: AN ULTRASTRUCTURAL STUDY UTILIZING FERRITIN-CONJUGATED ANTI-HUMAN FIBRINOGEN ANTIBODY. (1965) (57)
Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. (1983) (56)
The Chediak-Higashi syndrome: cytoplasmic sequestration in circulating leukocytes. (1967) (56)
Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. (1988) (55)
Influence of cytochalasin B on the shape change induced in platelets by cold. (1973) (55)
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. (1982) (55)
Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets. (1972) (54)
A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. (2001) (54)
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. (1982) (53)
Fine structural localization of adenosine triphosphatase in human platelets and other blood cells. (1965) (53)
Sebastian platelet syndrome: A new variant of hereditary macrothrombocytopenia with leukocyte inclusions (1990) (52)
Structural defects in inherited and giant platelet disorders. (1990) (52)
Phosphatidic acid releases calcium from a platelet membrane fraction in vitro. (1978) (52)
Platelet function, ultrastructure, and survival in the May-Hegglin anomaly. (1980) (51)
Neuronal connectivity in Caenorhabditis elegans (1985) (51)
Localization of 5‐Hydroxytryptamine in Blood Platelets: An Autoradiographic and Ultrastructural Study (1968) (51)
The influence of vitamin E quinone on platelet structure, function, and biochemistry. (1980) (51)
The blood platelet open canalicular system: a two-way street. (1991) (51)
Role of actin in platelet function. (1993) (50)
Micropipette aspiration of human platelets: influence of microtubules and actin filaments on deformability. (1984) (49)
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. (1978) (49)
The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion. (1977) (49)
The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages. (1978) (49)
An improved technique for the electronic measurement of platelet size and shape. (1976) (49)
The substructure of human platelet microtubules. (1968) (48)
Ceroid accumulation in a patient with progressive neurological disease. (1968) (48)
Centrosome dynamics in early embryos of Caenorhabditis elegans. (1998) (47)
Fulminating infection with herpes-simplex virus in premature and newborn infants. (1963) (47)
Neurone differentiation in cell lineage mutants of Caenorhabditis elegans (1982) (46)
The Chediak-Higashi syndrome: electrophysiological and electron microscopic observations on the peripheral neuropathy. (1967) (46)
The organization of microtubules and microtubule coils in giant platelet disorders. (1984) (45)
Morphometry of platelet internal contraction. (1984) (45)
Ultrastructural features on the platelet response to phorbol myristate acetate. (1974) (44)
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. (1977) (44)
Mechanisms of platelet production. (1989) (44)
Modification of human platelet response to sodium arachidonate by membrane modulation. (1981) (44)
The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation. (1977) (43)
Elevated urinary dolichol excretion in the Hermansky-Pudlak syndrome. Indicator of lysosomal dysfunction. (1987) (42)
Labile Aggregation Stimulating Substance (LASS): the Factor from Storage Pool Deficient Platelets Correcting Defective Aggregation and Release of Aspirin Treated Normal Platelets (1975) (42)
Platelets and atherosclerosis (1994) (42)
Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro. (1978) (42)
Influence of taxol on the response of platelets to chilling. (1982) (41)
Immune thrombocytopenia in severe neonatal infections. (1981) (41)
Effects of colchicine and vinca alkaloids on human platelets. II. Changes in the dense tubular system and formation of an unusual inclusion in incubated cells. (1968) (41)
The Chédiak-Higashi syndrome. Evidence that defective leukotaxis is primarily due to an impediment by giant granules. (1978) (41)
Electron microscopic studies of platelet secretion. (1974) (41)
A follow-up study of a patient with balint's syndrome (1969) (40)
Influence of cationic local anesthetics on the metabolism and ultrastructure of human alveolar macrophages. (1979) (40)
Platelet granule disorders. (1986) (40)
Exocytosis of secretory organelles from blood platelets incubated with cationic polypeptides. (1972) (40)
Inherited abnormalities of the platelet membrane and secretory granules. (1987) (40)
The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid. (1978) (40)
The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes. (1980) (39)
Effects of heat on platelet structure and function. (1968) (39)
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. (1980) (39)
alpha-Actinin deficiency in thrombasthenia: possible identity of alpha-actinin and glycoprotein III. (1979) (39)
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. (1981) (39)
A search for the platelet secretory pathway using electron dense tracers. (1970) (38)
Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. (1977) (38)
Defective platelet-fibrinogen interaction in hereditary canine thrombopathia. (1986) (38)
Vitamin E inhibits the release of calcium from a platelet membrane fraction in vitro (1979) (38)
The Hermansky-Pudlak syndrome: ultrastructure of bone marrow macrophages. (1973) (37)
An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips. (1979) (37)
The fine structure of freeze-fractured blood platelets. (1973) (37)
The fine structure of cell-free sickled hemoglobin. (1970) (36)
Overview article: biostructure of blood platelets. (1980) (36)
Comparison of the metabolism of alveolar macrophages from humans, rats, and rabbits: phorbol myristate acetate. (1978) (36)
Hypopigmentation in Angelman syndrome. (1993) (36)
Hereditary mucoepithelial dysplasia: a disease apparently of desmosome and gap junction formation. (1979) (36)
Biochemistry, physiology, and function of platelets stored as concentrates (1993) (36)
Influence of nitric oxide on agonist-mediated calcium mobilization in platelets. (1990) (36)
Abnormal cytoskeletal assembly in platelets from uremic patients. (1993) (35)
Platelet survival studies in Aldrich syndrome. (1966) (35)
Glutathione levels in human platelets display a circadian rhythm in vitro. (1985) (34)
Intravascular coagulation in acute stem cell leukemia successfully treated with heparin. (1967) (34)
Serotonin storage organelles in human megakaryocytes. (1971) (34)
Lysophosphatidic acids: III. Enhancement of neutrophil chemotaxis. (1980) (33)
The influence of aspirin and indomethacin on the platelet contractile wave. (1976) (33)
Ultrastructural features of erythrocyte and hemoglobin sickling. (1974) (33)
The ultrastructural localization and release of platelet lipids. (1965) (33)
Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. (1981) (33)
Influence of trifluoperazine on platelet aggregation and disaggregation. (1980) (32)
Spectrum of function of neutrophils from carriers of sex-linked chronic granulomatous disease. (1975) (32)
Giant organelles containing tubules in Chediak-Higashi lymphocytes. (1972) (32)
EPSILON AMINO CAPROIC ACID THERAPY AS A CAUSE OF INTRARENAL OBSTRUCTION IN HAEMATURIA OF HAEMOPHILIACS. (2009) (31)
Hermansky-Pudlak syndrome (HPS): a proposed block in glutathione peroxidase. (1973) (31)
Labile aggregation stimulating substance, free fatty acids, and platelet aggregation. (1976) (31)
Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. (1991) (31)
Degranulation of discoid platelets. (1972) (31)
Microtubule coils in spread blood platelets. (1984) (30)
Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin. (1981) (30)
Current concepts of platelet membrane response to surface activation. (1993) (30)
Idiopathic thrombocytopenic purpura and intracranial hemorrhage. (1981) (30)
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. (1978) (30)
Persistence of mobile receptors on surface- and suspension-activated platelets. (1994) (30)
Arrangements of actin filaments in the cytoskeleton of human platelets. (1984) (30)
Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism. (1991) (29)
In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. (1988) (29)
Tubular elements in platelet granules. (1968) (29)
Fine structural demonstration of acid phosphatase activity in Auer bodies. (1967) (29)
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. (1980) (29)
Electrical responses by guinea pig megakaryocytes (1978) (28)
Intraphagocytic Degradation of Group A Streptococci: Electron Microscopic Studies (1969) (28)
Platelet membrane responses to surface and suspension activation. (1990) (28)
Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment. (1982) (28)
Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. (2000) (28)
Effect of superoxide dismutase encapsulated in liposomes or conjugated with polyethylene glycol on neutrophil bactericidal activity in vitro and bacterial clearance in vivo. (1985) (28)
Ultrastructural localization of coagulation factor V in human platelets. (1986) (28)
Reversible neutrophil defect in patients with bacterial endocarditis. (1976) (28)
Calcium-induced erythrocyte rigidity: the roles of cellular metabolism, hydration, and ionic balance. (1980) (28)
An Immunoenzyme Histochemical Technique for the Detection of Platelet Antibodies from the Serum of Patients with Idiopathic (Autoimmune) Thrombocytopenic Purpura (ITP) (1977) (27)
Promotion of human platelet adhesion and aggregation by a synthetic, triple-helical "mini-collagen". (1994) (27)
An overview of platelet structural physiology. (1987) (27)
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation (1985) (27)
Rapid separation of platelet nucleotides by reversed-phase, isocratic, high-performance liquid chromatography with a radially compressed column. (1981) (27)
Effects of the addition of second‐messenger effectors to platelet concentrates separated from whole‐blood donations and stored at 4°C or –80°C (2000) (26)
Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets. (1999) (26)
Mobility of GPIIb-IIIa receptors within membranes of surface- and suspension-activated platelets does not depend on assembly and contraction of cytoplasmic actin. (1990) (26)
Cytochemical electron microscopic studies of the action of phorbol myristate acetate on platelets. (1974) (25)
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function (1986) (25)
Role of glutathione and glutathione peroxidase in human platelet arachidonic acid metabolism. (1989) (25)
Surface-activated bovine platelets do not spread, they unfold. (1990) (25)
Cell polarity in early C. elegans development. (1993) (25)
Binding of fibronectin to alpha-granule-deficient platelets (1983) (25)
A biphasic response of platelets to serotonin. (2009) (25)
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. (1977) (25)
Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade. (1981) (24)
Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets. (1979) (24)
Microtubule reassembly in surface-activated platelets. (1985) (24)
Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates. (1992) (24)
ARACHIDONIC ACID PEROXIDATION, PROSTAGLANDIN SYNTHESIS AND PLATELET FUNCTION (1978) (24)
Ferrous iron mediated oxidation of arachidonic acid: studies employing nitroblue tetrazolium (NBT). (1978) (24)
Epinephrine reduction of heme: implication for understanding the transmission of an agonist stimulus. (1982) (24)
The influence of prostaglandin endoperoxides on platelet ultrastructure. (1975) (24)
Massive bleeding from a Zenker's diverticulum: case report and review of the literature. (1994) (24)
Interaction of long-term stored platelets with vascular subendothelium. (1987) (24)
Response of normal aorta to endovascular grafting: a serial histopathological study. (1998) (24)
Influence of heat on platelet biochemistry, structure, and function. (1993) (23)
The structure and function of platelets, with emphasis on their contractile nature. (1976) (23)
Development of giant granules in platelets during prolonged storage. (1980) (23)
The Chediak-Higashi syndrome. Fine structure of giant inclusions in freeze-fractured neutrophils. (1973) (22)
Comparison of hemoglobin Köln erythrocyte membranes with malondialdehyde-reacted normal erythrocyte membranes. (1984) (22)
Variable deformability of irreversibly sickled erythrocytes. (1981) (22)
EDTA induced changes in platelet structure and function: influence on particle uptake. (1999) (22)
The influence of glutathione depleting agents on human platelet function. (1989) (22)
Interaction of microtubules and microfilaments in platelet contractile physiology. (1979) (22)
A possible role for cyclic nucleotides in the regulation of erythrocyte shape and permeability. (1976) (22)
Induction of receptor clustering, patching, and capping on surface-activated platelets. (1990) (22)
Fibrinogen receptors do not undergo spontaneous redistribution on surface-activated platelets. (1990) (22)
Tyrosinase positive oculocutaneous albinism among the Zuni and the Brandywine triracial isolate: biochemical and clinical characteristics and fertility. (1972) (22)
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. (1982) (22)
The origin of dense bodies in the surface coat of negatively stained platelets. (2009) (22)
Salicylic acid inhibition of the irreversible effect of acetylsalicyclic aicd on prostaglandin synthetase may be due to competition for the enzyme cationic binding site. (1981) (22)
The enigma of severe factor XI deficiency without hemmorrhagic symptoms. Distinction from Hageman factor and "Fletcher factor" deficiency; family study; and problems of diagnosis. (1967) (21)
Resection of metastases in Wilms' tumor: a report of three cases cured of pulmonary and hepatic metastases. (1968) (21)
The submembrane filaments of blood platelets. (1969) (21)
Giant platelet disorders in African-American children misdiagnosed as idiopathic thrombocytopenic purpura. (1999) (21)
Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis. (1978) (21)
Undifferentiated (embryonal) sarcoma of the liver in adults. (1995) (21)
Functional significance of mobile receptors on human platelets. (1993) (21)
Effects of cationic polypeptides on thrombasthenic and afibrinogenemic blood platelets. (1972) (21)
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. (1980) (20)
Clinical, histologic, cytologic, and ultrastructural characteristics of the oral lesions from hereditary mucoepithelial dysplasia. A disease of gap junction and desmosome formation. (1978) (20)
Platelet microtubules and giant granules in the Chediak-Higashi syndrome. (1978) (20)
Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy. (1980) (20)
Physical properties of red cells as related to effects in vivo. IV. Oxidant drugs producing abnormal intracellular concentration of hemoglobin (eccentrocytes) with a rigid-red-cell hemolytic syndrome. (1973) (20)
Effects of fractionated histones on nucleic acid synthesis in 6C3HED mouse ascites tumor cells and in normal spleen cells. (1968) (20)
The endogenous lectin of human platelets is an alpha-granule component. (1981) (19)
Platelet storage pool deficiency in pigs. (1986) (19)
Erythrocyte/endothelial interactions and the vasocclusive severity of sickle cell disease. (1981) (19)
Ultrastructural changes in stored platelets. (1992) (19)
Inhibition of ferrous iron induced oxidation of arachidonic acid by indomethacin. (1979) (19)
Platelet-leukocyte interactions following arterial endothelial injury. (1979) (19)
Platelet interaction with bacteria. V. Ultrastructure of congenital afibrinogenemic platelets. (1980) (19)
Effects of small latex particle uptake on the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. (1982) (18)
The Chediak-Higashi syndrome: quantitation of a deficiency in maximal bactericidal capacity. (1979) (18)
Reduction of ferric heme to ferrous by lipid peroxides: possible relevance to the role of peroxide tone in the regulation of prostaglandin synthesis. (1980) (18)
Further studies of natural killer cell function in Chediak-Higashi patients. (1982) (18)
Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. (1976) (18)
Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets. (1985) (18)
Organization of von Willebrand factor on surface-activated platelets. (1993) (17)
Influence of prostaglandins E1, E2, and arachidonate on melanosomes in melanocytes and keratinocytes of anagen hair bulbs in vitro. (1975) (17)
HOCl effects on the tight junctions of rabbit tracheal epithelium. (1996) (17)
Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. (1995) (17)
Influence of antioxidants on arachidonic acid metabolism and platelet function. (1994) (17)
Identification of platelet secretion in the electron microscope. (1973) (17)
Impairment of human alveolar macrophage oxygen consumption, and superoxide anion production by local anesthetics used in bronchoscopy. (1979) (17)
Surgical excision of pulmonary metastases. (1962) (17)
Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis. (1978) (17)
Platelet membrane ultrastructure and its changes during platelet activation. (1988) (17)
Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-Factor (1993) (17)
The Chédiak-Higashi syndrome: ring-shaped lysomomes in circulating monocytes. (1979) (17)
Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion. (1980) (17)
Interactions of zinc and arachidonic acid. (1981) (16)
Platelet membrane interactions. (1999) (16)
Irreversible platelet aggregation does not depend on lipoxygenase metabolites. (1985) (16)
Functional platelets after storage in vitro for 15--21 days. (1980) (16)
Dynamic redistribution of glycoprotein Ib/IX on surface-activated platelets. A second look. (1995) (16)
Cytochrome P-420: Tubular Aggregates from Hepatic Microsomes (1969) (16)
Retention of water and potassium by erythrocytes prevents calcium-induced membrane rigidity. (1978) (16)
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetate. (1975) (15)
Comparison of arachidonic acid metabolism in nasal polyps and eosinophils. (1987) (15)
Quantification of a novel dense granule protein (granulophysin) in platelets of patients with dense granule storage pool deficiency. (1992) (15)
Influence of Aspirin and Carbacyclin on Bovine Platelet Function (1992) (15)
Platelets in perspective. (1981) (15)
Classification of albinism in man. (1971) (14)
Micropipette Aspiration of Human Platelets after Exposure to Aggregating Agents (1986) (14)
Origin and function of platelet dense bodies. (1970) (14)
Isolation of circumferential microtubules from platelets without simultaneous fixation. (1986) (14)
The influence of albumin and calcium on human platelet arachidonic acid metabolism. (1980) (14)
Platelet secretory process. (1999) (14)
Comparative pharmacology of cyclooxygenase inhibitors on platelet function. (1985) (13)
Epinephrine and other activators of prostaglandin endoperoxide synthetase can reduce Fe3+-heme to Fe2+-heme. (1980) (13)
Perioperative management of a patient with Fechtner syndrome (2001) (13)
Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. (1980) (13)
Acute lymphoblastic leukemia with unusual cytoplasmic granulation: a morphologic, cytochemical, and ultrastructural study. (1986) (13)
Platelet glycosomes. (1999) (13)
Penicillin induced human platelet dysfunction and its reversal by epinephrine. (1983) (13)
Macrothrombocytopenia and progressive deafness: a new genetic syndrome. (1992) (13)
Interaction of arachidonic acid and heme iron in the synthesis of prostaglandins. (1980) (13)
Methotrexate liver toxicity. (1969) (12)
Megakaryoblastic transformation of Ph positive chronic granulocytic leukemia. (1985) (12)
Separate and combined interactions of fibrinogen-gold and latex with surface-activated platelets. (1990) (12)
Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation. (1982) (12)
Defibrination syndrome in an infant born after abruptio placentae. (1968) (12)
Isolation of microtubule coils from platelets after exposure to aggregating agents. (1986) (12)
The influence of phorbol myristate acetate on the metabolism of neutrophils from carriers of sex-linked chronic granulomatous disease. (1975) (12)
"HISTIOCYTOSIS X" TREATED WITH VINBLASTINE SULFATE (NSC-49842). (1964) (12)
Influence of a calcium dependent protease inhibitor on platelet activation and secretion. (1987) (11)
Comparison of bovine and human platelet deformability, using micropipette elastimetry. (1989) (11)
Development of a simple embedding procedure allowing immunocytochemical localization at the ultrastructural level. (1988) (11)
Bleeding diathesis associated with variant von Willebrand factor in a Simmental calf. (1994) (11)
Micropipette aspiration of human blood platelets: a defect in Bernard-Soulier's syndrome. (1984) (11)
Inhibition of prostaglandin (PG) synthesis in sheep vesicular gland microsomes (SVGM) by nitroblue tetrazolium (NBT) and vitamin E (VE). (1979) (11)
The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes. (1977) (11)
Changes in platelet microtubules and granules during early clot development. (1967) (11)
Coronary artery disease: an overview of risk factors. (1993) (11)
Induction of GPIb/IX-vWF receptor-ligand translocation on surface-activated platelets. (1995) (11)
AN ULTRASTRUCTURAL INVESTIGATION OF THE FIBRIN CLOT UTILIZING FERRITIN-LABELLED ANTI-HUMAN FIBRINOGEN ANTIBODY. (1964) (10)
Rapid separation of nucleotides from granulocytes by isocratic, reversed-phase high-performance liquid chromatography. (1982) (10)
Chediak-Higashi syndrome: variable cytochemical reactivity of giant inclusions in polymorphonuclear leukocytes. (1980) (10)
Redistribution of membrane glycoproteins in platelets activated under flow conditions. (1996) (10)
Alterations of platelet ultrastructure in patients with carcinoid syndrome. (1969) (10)
Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function. (1981) (10)
The irreversibly sickled cell. (1982) (10)
Micropipette aspiration of human platelets: influence of rewarming on deformability of chilled cells. (1986) (10)
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. (1986) (10)
Platelet plasma membrane is equally distributed between surface and osmotically-evaginable surface-connecting membrane, independent of size, subpopulation or species. (1992) (10)
Relationship of actin filament assembly to clearance of fibrinogen gold, GPIIb‐IIIa complexes on spread platelets (1995) (10)
Uptake of vWF-anti-vWF complexes by platelets in suspension. (1996) (10)
High frequency of elongated platelet forms in guinea pig blood: ultrastructure and resistance to micropipette aspiration. (1990) (9)
Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. (1982) (9)
Tubular polymers of normal human hemoglobin. (1970) (9)
Propylene glycol-induced Heinz body formation and D-lactic acidosis in cats. (1989) (9)
Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C. (2000) (9)
Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor. (1974) (9)
Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis. (1987) (9)
The Chediak-Higashi syndrome: microtubules in monocytes and lymphocytes. (1979) (9)
Influence of ionized calcium on thrombin-induced down regulation of GPIb/IX receptors on human platelets. (1997) (9)
Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets. (1991) (9)
Influence of various doses of aspirin (in vivo) on platelet arachidonic acid metabolism (ex vivo) and function. (1994) (9)
Alteration in the surface morphology of synchronized B-16 melanoma cell during the cell cycle. (1975) (8)
PROLONGED BLEEDING TIME IN A PATIENT WITH PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY: OBSERVATIONS ON CORRECTION OF THE BLEEDING TIME BY PLATELET TRANSFUSION. (1963) (8)
Polyphasic linkage between protein solubility and ligand binding in the hemoglobin-polyethylene glycol system. (1980) (8)
Simple method for the separation of monohydroxy fatty acid metabolites of arachidonate metabolism. (1982) (8)
Filtration deformability of rabbit pulmonary macrophage. (1982) (8)
Ultrastructural physiology of platelets with randomly dispersed rather than circumferential band microtubules. (1983) (8)
Enteric-coated aspirin, platelet cyclooxygenase activity and function. (1984) (8)
THE CORRECTION OF PROLONGED BLEEDING TIMES IN TWO BROTHERS BY PLATELET TRANSFUSIONS DESPITE NORMAL IN VITRO PLATELET TESTS. (1964) (8)
Alcohol consumption in the guinea pig is associated with reduced megakaryocyte deformability and platelet size. (1992) (8)
Detergent-resistant cytoskeleton of the surface-activated platelet differs from the suspension-activated platelet cytoskeleton. (1992) (8)
Self-association of bound fibrinogen on platelet surfaces. (1997) (8)
Denture identification. (1984) (8)
Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. (1992) (8)
Prelabeled glycoprotein Ib/IX receptors are not cleared from exposed surfaces of thrombin-activated platelets. (1996) (8)
Fine structural alterations induced in erythocytes by phorbol myristate acetate. (1978) (8)
Fechtner syndrome: physiologic analysis of macrothrombocytopenia. (2000) (7)
The interplatelet zone. (1970) (7)
Isolation of microtubule coils from normal human platelets. (1985) (7)
Recent advances in platelet structural physiology. (1978) (7)
Platelet hypersensitivity induced by 1-chloro-2, 4-dinitrobenzene, hydroperoxides and inhibition of lipoxygenase. (1989) (7)
Primary thrombocythaemia in childhood: symptomatic episodes and their relationship to thromboxane A2, 6-keto-PGE1 and 12-hydroxy-eicosatetraenoic acid production: a case report. (1987) (7)
Characterization of the murine gene corresponding to human Hermansky-Pudlak syndrome type 3: exclusion of the Subtle gray (sut) locus. (2001) (6)
The adrenergic responsiveness of Down syndrome cells. (1982) (6)
Influence of thrombolytic agents on human platelet function. (1991) (6)
Reduction of heme by lipid peroxides and its potential relevance to understanding control of cyclo-oxygenase activity. (1981) (6)
Ultrastructural analysis of platelet contractile apparatus. (1992) (6)
Enzyme therapy XIV. Comparison of methods for enzyme entrapment in human erythrocytes. (1980) (6)
High-resolution backscatter electron detection of cell surface molecules on human platelets using the double-layer coating method and cryo field emission scanning electron microscopy. (1997) (6)
Effects of hypertonic stress on the fine structure of sickled erythrocytes. (1970) (6)
Ultrastructural modifications in platelet membranes and cytoskeleton following activation. (1983) (6)
Lymphocyte inclusions. (1972) (6)
Dose-Dependent Inhibition of Experimental Arterial Thrombosis by Carbenicillin and Ticarcillin (1978) (6)
Evaluation of the role of diacyglycerol in calcium-induced erythrocyte shape change and rigidity. (1980) (6)
Rapid separation of tumor-promoting agents, phorbol and phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate) by high-pressure liquid chromatography. (1974) (6)
Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase. (1987) (5)
Artificial microvascular graft thrombosis: the consequences of platelet membrane glycoprotein Ib inhibition and thrombin inhibition. (1993) (5)
Micellar properties of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestan-26-oyl taurine and relationship to in vitro red cell disruption. (1979) (5)
Platelet secretory granules and associated proteins. (1993) (5)
Anti-nuclear antibodies in normal human subjects. (1967) (5)
Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. (1994) (5)
Possible mechanisms of epinephrine actions in quin-2-loaded platelets refractory to arachidonic acid. (1993) (5)
The alpha adrenergic response of Down's syndrome platelets. (1983) (5)
The influence of metabolities on the assay of platelet serotonin. (1977) (5)
The down-side of platelet interaction with surfaces. (1994) (5)
Splenocytes from bile duct ligated rats do not elicit a normal immune response in the intact host. (1994) (5)
Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis. (1979) (4)
Influence of thrombin in suspension, surface activation, and high shear on platelet surface GPIb/IX distribution. (1999) (4)
May-Hegglin anomaly: A rare cause of thrombocytopenia (1992) (4)
Epsilon-amino-caproic acid for hematuria in hemophilia. (1962) (4)
Localization of GPIb/IX and GPIIb/IIIa on Discoid Platelets. (1995) (4)
Genome maps. VI. Caenorhabditis elegans. Wall chart. (1995) (4)
Hereditary mucoepithelial dysplasia, a disease of gap junction and desmosome formation. (1982) (4)
Epinephrine-induced reversal of aspirin effects on platelet deformability. (1988) (4)
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin. (1996) (4)
Micropipette aspiration of guinea pig megakaryocytes: absence of fragmentation and dependence on maturation stage. (1989) (4)
An improved method for measuring endogenous serotonin in platelets of patients with Hermansky-Pudlak syndrome. (1988) (4)
Ultrastructural expression of P-selectin on surface activated platelets. (1996) (4)
Failure to mobilize intracellular calcium in response to thrombin in a patient with familial thrombocytopathy characterized by macrothrombocytopenia and abnormal platelet membrane complexes. (1993) (4)
The secretory mechanisms in equine platelets are independent of cytoskeletal polymerization and occur through membrane fusion (2010) (4)
Metabolic and morphologic effects of intraerythrocytic calcium: implications for the pathogenesis of sickel cell disease. (1977) (4)
Epinephrine and platelet function. (1997) (4)
Arachidonic acid metabolism in thrombocytes and vascular tissues of turkeys. (1985) (4)
Talin does not associate exclusively with alpha 2b beta 3 integrin in activated human platelets. (1995) (4)
On the Implications of Laterally Mobile Cortical Tension Elements for Cytokinesis (1987) (4)
Ascorbic acid modulation of splenic cell cyclic GMP metabolism. (1979) (4)
Effects of Coichicine and Vinca Alkaloids on Human Platelets (2007) (4)
Influence of intracellular chelating agents on formation of spike-like pseudopods by human platelets. (1999) (4)
Fate of the GPIb/IX receptor complex following activation of human platelets. (1996) (4)
Effects of colchicine and vinca alkaloids on human platelets. 3. Influence on primary internal contraction and secondary aggregation. (1969) (4)
Mutations in the melanin pigment system in man resulting in features of oculo cutaneous albinism (1972) (4)
Influence of Adrenergic Receptor Blockade on Aspirin-induced Inhibition of Platelet Function. (1990) (3)
Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor function. (1989) (3)
Influence of calcium antagonists on thrombin-induced calcium mobilization and platelet-vessel wall interactions. (1992) (3)
Membrane defects in inherited disorders of platelet function. (1982) (3)
Brassica seedling establishment. (1984) (3)
Influence of microtubule stabilization on platelet physiology. (1982) (3)
Inhibition of platelet aggregation by novel triphenylethylene analogs. (1986) (3)
Delivery of platelets from megakaryocytes. (1990) (3)
Aspirin in ischemic heart disease--an overview. (1993) (3)
Thrombin-induced inhibition of platelet agglutination by von Willebrand factor (vWF): reversal by ionized calcium. (1996) (3)
Erythrocytic ecdysis. An unusual morphologic finding in a case of sickle cell anemia with intercurrent cold-agglutinin syndrome. (1979) (3)
Arachidonic acid metabolism in nasal polyps and allergic inflammation. (1981) (3)
Scanning electron microscopy of erythrocyte deformation: the influence of a calcium ionophore, A23187. (1976) (3)
Differences in Platelet Storage Pool Deficiency (SPD) of Hermansky Pudlak Syndrome (HPS) and Non-Albinos (NA) (1975) (3)
Physiology and function of platelets from patients with Alzheimer's disease. (1996) (3)
[The Sebastian platelet syndrome. A new form of hereditary thrombocytopenia with giant thrombocytes and inclusion bodies in granulocytes]. (1990) (2)
Influence of cytochalasin B (CB) on GP Ib distribution after thrombin or TRAP and before surface activation. (1997) (2)
Platelet activity of antilymphocyte serum (ALS) preparations. (1973) (2)
Aspirin, prostaglandin E1 and Quin-2 AM-induced platelet dysfunction: restoration of function by noradrenalin. (1990) (2)
1-Arachidonyl-monoglyceride causes platelet aggregation--implications for an acylglycerol acylhydrolase involvement in control of prostaglandin synthesis. (1981) (2)
Digital integration of granulocyte aggregation responses. A simple and reproducible method for the quantitation of granulocyte adhesiveness. (1980) (2)
Distribution of GPlb on the in resting platelets. (1998) (2)
Platelet Dysfunction Induced by Parenteral Administration of Carbenicillin and Ticarcillin (1975) (2)
Left hepatic choledochal cyst. (1996) (2)
Interleukin 1 enhances arterial thrombogenicity in vitro. (1989) (2)
Time-lapse cinemicrography and scanning electron microscopy of platelet formation by megakaryocytes: a commentary. (1983) (1)
Effects of pH on Arachidonic Acid Induced Platelet Aggregation (1975) (1)
An Immunoenzyme Histochemical Technique for Detecting Platelet Antibodies from the Serum of Children with Idiopathic Thrombocytopenic Purpura (ITP) (1977) (1)
Morphological and Functional Aspects of Cellular Hemostatic Mechanisms (1996) (1)
Influence of cytochalasin B (CB) on platelet aggregation. (1971) (1)
MANAGEMENT OF SPONTANEOUS SPLENIC RUPTURE IN AHG DEFICIENT HEMOPHILIA. (1965) (1)
Localization ofPlatelet Prostaglandin Production in thePlatelet DenseTubular System (1976) (1)
Influence of low dose enteric-coated aspirin on platelet function. (1992) (1)
Responses of Afibrinogenemic Platelets to Bacteria (1979) (1)
Platelet ultrastructure in relation to platelet function. (1978) (1)
Interspecies variation in erythrocyte calcium response. (1978) (1)
DIFFERENT SITES FOR FIBRINOGEN AND FIBRIN RECEPTORS ON PLATELETS (1987) (1)
Alterations in lipid fluidity induced by cholesterol and cholesterol hemisuccinate modulate the organization of microtubule skeletons in epithelial cells. (1987) (1)
a-Actinin Deficiency in Thrombasthenia Possible Identity of a-Actinin and Glycoprotein III (2007) (1)
Quantitation of chemotaxis and maximal bactericidal capacity of mature neutrophils in chronic myelogenous leukemia. (1979) (1)
Platelet particle processing: an example of surface sorting on single cells. (1990) (1)
THE CHEDIAK‐HIGASHI ANOMALY AND THE ALEUTIAN TRAIT IN MINK: HOMOLOGOUS DEFECTS OF LYSOSOMAL STRUCTURE * (1968) (1)
Antinuclear Antibodies—Attempts at Ultrastructural Localization∗ (1968) (1)
Concurrent effects of microsieve aspiration and the ionophore A23187 on the morphologic characteristics of the surface of normal erythrocytes. (1980) (1)
Cytoskeletal changes in aging platelets. (1985) (1)
THE AMERICAN JOURNAL OF PATHOLOGY (2007) (0)
Influence of Psoralen and Ultraviolet Therapy on Platelet Function and Arachidonic Acid Metabolism in Patients with Vitiligo (1987) (0)
" Separable Function of Platelet Release Reaction and Clot Retraction (2017) (0)
Renal transplantation in Epstein syndrome. (1987) (0)
263 A comparison of human eosinophil and nasal polyp arachadonic acid metabolism (1983) (0)
Vitamin E and platelets: cooperative interactions with nitroblue tetrazolium on inhibition of adhesion, aggregation and secretion. (1979) (0)
Mechanisms involved in platelet surface interactions (1990) (0)
Effects of Liquid Storage in a High pH Anticoagulant on the Circulation of Baboon Platelets. (1982) (0)
Effect of atropine on platelet structure and function. (1969) (0)
Vitamin E inhibits the release of calcium from a platelet fraction in vitro. (1979) (0)
Erratum: Influence of thrombolytic agents on human platelet function (Thrombosis Research (1991) 62 (319-394)) (1991) (0)
Alpha tocopherol quinone (alpha TQ): a potent inhibitor of platelet function. (1981) (0)
PLATELET RESPONSE TO IMMUNOLOGICAL INJURY (1974) (0)
Membrane abnormalities in congenital disorders of human blood platelets. (1982) (0)
Developing neurons, in brief. Development of nerve cells and their connections. By W. G. Hopkins and M. C. Brown. Cambridge University Press, 1983. Pp. 143. £16.00, paperback £6.95 (1984) (0)
EPINEPHRINE INDUCED POTENTIATION OF ARACHIDONATE AGGREGATION IN OUIN 2 LOADED PLATELETS IS NOT MEDIATED BY ELEVATION OF CYTOSOLIC CALCIUM (1987) (0)
Binding of Fibronectin to o -Granule-deficient Platelets (2002) (0)
Comparative biochemical and ultrastructural studies of capillaries from normal humans, normal mice, and human cerebral astrocytomas. (1980) (0)
[Effect of plasmacytapheresis on thrombocyte ultrastructure]. (1985) (0)
The importance of history in the diagnosis of congenital coagulation disorders. (1962) (0)
Imaging of surface-adherent human-blood platelets by atomic-force microscopy (AFM) (1996) (0)
Interactions of blood with solid and porous endocardial electrodes for cardiac pacemakers. (1980) (0)
Introductory Remarks: Introductory Comments (1981) (0)
A SIMPLIFIED APPROACH FOR THE DETECTION OF COAGULATION DISORDERS. (1965) (0)
HYDROLYSIS OF OXAZIRIDINES. PART 4. THE EFFECTS OF SUBSTITUENTS ON THE KINETICS AND MECHANISMS OF THE ACID‐CATALYZED REACTIONS (1979) (0)
Persistent thrombocytosis small platelets and enlarged alpha granules in patients with kawasakis syndrome (1989) (0)
Proceedings: Effects of pH on arachidonic acid induced platelet aggregation. (1975) (0)
Activated Platelets in Suspension (2007) (0)
C0408: Selective Serotonin Reuptake Inhibitors Have a Direct Inhibitory Effect on Platelet Response to Thrombin and Cytoskeletal Assembly (2014) (0)
EFFECT OF SELECTIVE INHIBITION OF PLATELET THROMBOXANE ON PLATELET-VESSEL WALL INTERACTION IN VIVO (2018) (0)
Cell polarity in early C. elegans development. (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With J. Graham White?

J. Graham White is affiliated with the following schools:

J. Graham White's Academic­Influence.com Rankings

Why Is J. Graham White Influential?

J. Graham White's Published Works

Published Works

What Schools Are Affiliated With J. Graham White?

J. Graham White's AcademicInfluence.com Rankings